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Abstract 
Fibronectins (FN) contain sites, in addition to the cell recognition site RGD in the tenth type III domain (FIIHO), that are required for adhesive 
activity. The role of FBI10 and the adjacent FBI9 was analysed in functional cell adhesion assays recombinant FIII domains in which the domain 
boundaries were strictly conserved. FII19 had no adhesive activity. FIIIlO, and FIII9 plus FIIIlO had less activity than FN, whereas the activity of 
FIII9-10 was similar to FN. We conclude that FBI9 acts synergistically with FBI10 in cell adhesion, and that this synergy is dependent upon the 
structural integrity of the FIII9-10 pair of domains. 
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1. Introduction 
Fibronectins (FN) are a group of large glycoproteins 
that mediate the adhesion of many cell types to the ex- 
tracellular matrix (ECM), and have a critical role in 
many biological processes uch as development, differen- 
tiation, wound healing, tumorigenesis and metastasis [I]. 
The adhesive function of FN is facilitated by multiple 
binding sites for cells and for components of the ECM, 
such as collagen, fibrin and heparin. The binding sites 
are located in distinct structural domains on the FN 
molecule, called type I, type II and type III domains [2], 
(Fig. 1). FN type III (FIII) domains are common struc- 
tural motifs that have been identified in many eukaryotic 
and prokaryotic proteins with diverse functions [3]. 
Many cell types bind to the central cell binding domain 
(CCBD) which spans the eighth, ninth and tenth type III 
domains (FII18, FII19 and FIIIlO) via the integrin family 
of cell surface receptors [4]. The minimal sequence in the 
CCBD for cell recognition and binding has been mapped 
to RGD [5], at the N-terminus of FIIIlO. However RGD 
does not mimic the full adhesive capacity of FN, or of 
a 37 kDa proteolytic fragment of FN containing the 
CCBD, in cell adhesion assays [6], suggesting that this 
region contains sites, in addition to RGD, that are re- 
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quired for cell adhesion. The presence of additional sites 
in the CCBD that are required for the interaction of FN 
with both a5jIl and aIIbB3 integrins, has been confirmed 
in functional, cell binding and cell adhesion studies of 
recombinant fragments of FN containing deletions in 
this region, and by mapping the epitopes of monoclonal 
antibodies to the CCBD that disrupt adhesive function 
w-91. 
Structural studies of FIII domains [lO_121 have led to 
a greater understanding of the mechanisms involved in 
molecular ecognition and cell adhesion. The studies also 
indicate that it is important to understand how the func- 
tional sites required for cell adhesion interact in the con- 
text of the structural domains in which they reside. 
We have previously shown that the intact FIIIlO do- 
main has only slightly more adhesive activity than a 
short peptide containing RGD [lo]. In the present study 
we investigated the interaction of FII19 and FIIIlO struc- 
tural domains in the adhesion of fibroblasts which bind 
to FN via a.5/?1. We assessed the adhesive activity of 
FII19 and FIIIlO, expressed singly or as a pair, as fusion 
proteins of glutathione S-transferase (GST), in which the 
FIII domain boundaries had been strictly maintained. 
2. Materials and methods 
2. I Expression of recombinant FIII-GST fusion proteins 
cDNAs encoding the FBI9 (residues 1,3251,415) and FIB10 (resi- 
dues 1,41&l ,509) domains, and the FIII9-10 pair of domains, were 
amplified from a human FN cDNA fragment, pFH154 [13], by the use 
of oligonucleotide primers in polymerase chain reactions: FIII9, 
5’ GGGTCTTGATTCCCCAACTGG, 3’ TTATTATGTTGATTGT- 
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TGGCCAATCA; FIIIlO S’, GGTTTCTGATGTTCCGAGGGA, 
3’ TTATTATGTTCGGTAATTAATGGAAA. 
Amplified cDNAs were cloned into the SmaI site of pGEX2T [14], 
and the sequence verified by using the Sequenase kit (Pharmacia) and 
3’ pGEX2T oligonucleotide sequencing primer TTTCACCGTCAT- 
CACCGA. Recombinant FIII-GST fusion proteins were expressed 
and purified as described by Smith et al. [14]. The purity and M, of the 
fusion proteins was confirmed by 15% SDS-PAGE (Fig. 2) and C8 
reverse-phase HPLC. For the inhibition assays, the domains were puri- 
fied further by cleavage of the fusion protein with l-5 U human plasma 
thrombin (Sigma) per mg fusion protein as described [14]. The throm- 
bin was inactivated by incubation with 1 mM phenylmethylsulfo- 
nylfluoride, and the FIII domains concentrated and equilibrated with 
PBS by centrifugation through a Centricon 3 (Amicon). Cleaved do- 
mains were analysed by SDS-PAGE, as above, and the molecular 
weights of the proteins confirmed by injecting a solution of the protein 
into the electrospray system of a VG BIO Q quadrupole mass spectro- 
meter. The concentration of the proteins was determined by measuring 
the absorbance at 280 nm, and the extinction coefficient for each pro- 
tein was calculated on the basis of the number of tyrosines and trypto- 
phans in the amino acid sequence. 
2.2. Cell spreading assuys 
Fig. 2. 15% SDS-PAGE of purified GST-FIII fusion proteins FIII9, 36 
kDa; FIIIlO, 36 kDa; FIII9-IO,46 kDa and GST, 26 kDa (A) and the 
cleaved omains FIII9,9 kDa; FIIIlO, 9.5 kDa and FIII9-10, 18.5 kDa 
(B) stamed with Coomassie blue. The molecular weight markers and 
their relative mass are shown. 
Baby hamster kidney (BHK) cells were maintained in MEM and 10% 
FCS at 37°C. Cell spreading assays were carried out according to 
methods described previously by others [15], with some modifications. 
In each experiment, the surface of replicate wells of 96 well plates 
(Nunclon) was coated with doubling dilutions of 200 &ml of the 
FIII-GST fusion proteins, FN (human plasma; Sigma) or GST, in PBS, 
or PBS, for 16 h at 4°C. Uncoated plastic was blocked with 1% bovine 
serum albumin (BSA) in PBS for 1 h at 20°C. lo4 BHK cells were 
inoculated into each well in MEM, and incubated for 1 h at 37’C. 
Adherent cells were washed gently with PBS and fixed with 4% formal- 
dehyde; 4% gluteraldehyde in PBS. Cells were viewed by the use of 
phase contrast microscopy. In each experiment, at least 200 cells in four 
fields were counted in each duplicate well, and scored for either rounded 
or spread morphology. Cells that appeared elongated and non-refrac- 
tile, with the nucleus and nucleoli clearly visible, were scored as spread; 
refractile cells in which the nucleus was not visible were scored as round. 
The number of spread cells was expressed as a percentage of the total 
number of cells counted. 
terial lysate, whereas expression of FIII9-GST was low, 
and the protein was only partially soluble. The fusion 
proteins and the cleaved FIII domains migrated as single 
bands on SDS-PAGE, and eluted in a single peak from 
a C8, reverse-phase column by HPLC (data not shown). 
3.2. BHK cells adopt a more spread morphology on 
FIII9-IO-GST than on FIIIIO-GST 
For the inhibition of spreading assays, wells of 96-well plates were 
coated with 5 &ml FN, and blocked as described above. 25 ~1 cleaved 
FIII domain in PBS, or PBS, were added to each well. 104 BHK cells 
in 75 ~1 MEM were inoculated into each well and incubated for 1 h 
at 37’C. Adherent cells were fixed and scored as described for the cell 
spreading assays. 
3. Results 
3.1. Expression of FIII-GST fusion proteins 
FII19, FIIIlO, and FIII9-10 were expressed as fusion 
proteins of GST. Fig. 2 shows SDS-PAGE analysis of 
the FIII-GST fusion proteins after purification by affin- 
ity adsorption onto glutathione-Sepharose beads. 
FIIIlO-GST and FIII9-10-GST were highly expressed 
and the expressed protein was highly soluble in the bac- 
The FIII-GST fusion proteins were tested for their 
capacity to support spreading of BHK cells on plastic 
coated with lOO&ml fusion proteins (Fig. 3). BHK cells 
attached poorly to FIII9-GST, and the cells remained 
rounded (Fig. 3A). Cells adhered to FIIIlO-GST more 
efficiently, although many cells remained rounded and 
appeared more refractile. Some cells exhibited a spread 
morphology, but to a lesser extent than cells plated onto 
FN (compare Fig. 3B with 3E). The morphology of cells 
plated onto FIII9-GST + FIIIlO-GST (Fig. 3C) was 
similar to that of cells on FIIIlO-GST. Most cells plated 
onto plastic coated with FIII9-l&GST were well 
spread, and very few cells remained rounded (Fig. 3D), 
and were morphologically comparable to cells plated 
onto FN (compare Fig. 3C with 3E). Very few cells 
attached to GST (Fig. 3F). 
3.3. FIII9-IO-GST mimics the adhesive activity of FN 
The graph in Fig. 4A shows the quantitative data for 
librin 
hcparin librin , 
9 COOH 
EDIIIB EDIIIA IIICS 
Fig. 1. Diagram of the FN subunit illustrating the organisation of the type I (black boxes), type II (circles) and type III (white boxes, numbered l-15) 
domains and the alternatively spliced domains EDIIIA, EDIIIB and IIICS. Fibrin, heparin and collagen binding sites, the central cell binding domain 
(CCBD) and cell binding sites CSl and CS5 are also shown. 



